{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:06:10Z","timestamp":1789679170154,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.transproceed.2026.08.004","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:55:29Z","timestamp":1789678529000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7960-4477","authenticated-orcid":false,"given":"Fatih","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutay","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Ugras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degercan","family":"Yesilyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erc\u00fcment","family":"G\u00fcrl\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Kiyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2026.08.004_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5009\/gnl19265","article-title":"Expanding indications for liver transplant: tumor and patient factors","volume":"15","author":"Chu","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0002","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3390\/cancers14112662","article-title":"Liver transplant oncology: towards dynamic tumor-biology-oriented patient selection","volume":"14","author":"Ilmer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0003","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3350\/cmh.2022.0060","article-title":"Prediction models of hepatocellular carcinoma recurrence after liver transplantation: a comprehensive review","volume":"28","author":"Kim","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-6143.2011.03788.x","article-title":"Micro-RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation","volume":"12","author":"Barry","year":"2012","journal-title":"Am J Transplantation"},{"issue":"4","key":"10.1016\/j.transproceed.2026.08.004_bib0005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.transproceed.2019.01.089","article-title":"Over expression Mir-21 is associated with recurrence in patients with hepatit B vir\u00fcs-mediated hepatocellular carcinoma undergoing liver transplantation","volume":"51","author":"Dundar","year":"2019","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.transproceed.2026.08.004_bib0006","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.transproceed.2022.05.024","article-title":"Blood-based biomarkers in AFP normal\/stable hepatocellular carcinoma: diagnostic and prognostic relevance of Mir-10b for patients on liver transplant list","volume":"54","author":"Aksoy","year":"2022","journal-title":"Transplant proc"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0007","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinoma in patient with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1016\/j.transproceed.2026.08.004_bib0008","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s12029-020-00424-w","article-title":"Liver transplantation for hepatocellular carcinoma; Malatya experience and proposal for expanded criteria","volume":"51","author":"\u0130nce","year":"2020","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7150\/ijbs.28720","article-title":"Development and validation of a prognostic nomogram in AFP-negative hepatocellular carcinoma","volume":"15","author":"Wang","year":"2019","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10.1016\/j.transproceed.2026.08.004_bib0010","article-title":"Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis","volume":"7","author":"Carr","year":"2021","journal-title":"J Transl Sci"},{"issue":"2","key":"10.1016\/j.transproceed.2026.08.004_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000484564","article-title":"Characteristics of hepatocellular carcinoma aggressiveness in Turkish patients","volume":"94","author":"Akkiz","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0012","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3390\/cancers14112777","article-title":"Expansion of liver transplantation criteria for hepatocellular carcinoma from Milan to UCSF in Australian and New Zealand and justification for Metroticket 2.0","volume":"14","author":"Barreto","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.transproceed.2026.08.004_bib0013","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/cancers14020419","article-title":"Liver transplantion for hepatocellular carcinoma: how should we improve thresholds?","volume":"14","author":"Shimamura","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0014","article-title":"The combination of AFP and \u201cup-to-seven\u201d criteria may be a better strategy for liver transplantation in Chinese cirrhotic HCC patients","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4254\/wjh.v15.i2.129","article-title":"Current status and prospect of treatments for recurrent hepatocellular carcinoma","volume":"15","author":"Yang","year":"2023","journal-title":"W J Hepatol"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40644-021-00425-3","article-title":"Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JHC.S174549","article-title":"Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria","volume":"6","author":"Amado","year":"2018","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0018","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.21993","article-title":"Tumor recurrence following livrer transplantation for hepatocellular carcinoma: role of tumor proliferation status","volume":"16","author":"Marshall","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0019","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.31210","article-title":"Liver transplantation outcomes in a U.S multicenter cohort of 789 patients with hepatocellular carcinoma presenting beyond Milan Criteria","volume":"72","author":"Kardashian","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10333","article-title":"Patient selection for downstaging of hepatocellular carcinoma prior to liver transplantation-adjusting the odds?","volume":"35","author":"Seehofer","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14218\/JCTH.2019.00050","article-title":"Liver transplantation beyond Milan criteria","volume":"8","author":"Lingiah","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0022","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/lt.22037","article-title":"The Milan Criteria: no room on the metro for the King?","volume":"16","author":"Marsh","year":"2010","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0023","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomized, controlled, phase 2b\/3 trial","volume":"21","author":"Mazzaffero","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0024","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","article-title":"Liver transplantation for hepatocellular carcinoma. Working Group Report from ILTS transplant onocology consensus conference","volume":"104","author":"Mehta","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.08.004_bib0025","first-page":"288","article-title":"Morphological features of advanced hepatocellular carcinoma as a predictor of down-staging and liver transplantation: an intention-to-treat analysis","volume":"16","author":"Barakat","year":"2021","journal-title":"Liver Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526004550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134526004550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:55:33Z","timestamp":1789678533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134526004550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0041134526004550"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.08.004","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}